ArticleMaedica2023
An Unusual Case of Allergic Contact Dermatitis Due to Nepafenac Eye Drop.
Article in Maedica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eyelid dermatitis is a common occurrence in several skin disorders, including seborrheic dermatitis, atopic dermatitis and psoriasis. However, it is primarily associated with allergic contact dermatitis (ACD). Here, we present a case of 51-year-old woman who developed pruritic erythema of the eyelids after using 0.1% Nepafenac eye drops. Nepafenac is a non-steroidal anti-inflammatory drug (NSAID) commonly prescribed as eye drops for various inflammatory eye conditions. Instances of ACD caused by Nepafenac eye drops are exceedingly rare based on available case reports. Nevertheless, it is important to consider ACD as a potential cause when a patient with eyelid dermatitis has a history of Nepafenac eye drop usage. The Naranjo algorithm, which was used for assessing causality, determined the likelihood of this case being a possible instance of ACD due to Nepafenac (Naranjo score=3).
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.